NCT00651859View on ClinicalTrials.gov

Safety and Efficacy Study of Bimatoprost in Ethnically Japanese Patients With Open-Angle Glaucoma or Ocular Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

January 31, 2004

Study Completion Date

January 31, 2004

Conditions
GlaucomaOcular Hypertension
Interventions
DRUG

Bimatoprost 0.01% Ophthalmic Solution

Bimatoprost 0.01% ophthalmic solution 1 drop instilled in each eye once daily in the evening between 19:00 and 21:00

DRUG

Bimatoprost 0.03% Ophthalmic Solution

Bimatoprost 0.03% ophthalmic solution 1 drop instilled in each eye once daily in the evening between 19:00 and 21:00

DRUG

Bimatoprost Vehicle Ophthalmic Solution

Bimatoprost vehicle ophthalmic solution 1 drop instilled in each eye once daily in the evening between 19:00 and 21:00

Trial Locations (1)

Unknown

San Francisco

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY